Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03902184
Title IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma (TELLOMAK)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Innate Pharma

anaplastic large cell lymphoma

mycosis fungoides

Sezary's disease

angioimmunoblastic T-cell lymphoma

peripheral T-cell lymphoma


Gemcitabine + Lacutamab + Oxaliplatin


Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.